Methods for identifying modulators of NF-KB activity

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S018000, C435S029000

Reexamination Certificate

active

07081343

ABSTRACT:
The present invention provides methods for identification of agents that modulate NF-κB activity through modulation of the acetylation and deacetylation of the RelA subunit of NF-κB.

REFERENCES:
patent: 5804374 (1998-09-01), Baltimore et al.
patent: 6037133 (2000-03-01), Li
patent: 6150090 (2000-11-01), Baltimore et al.
patent: 6242253 (2001-06-01), Karin et al.
patent: 6242254 (2001-06-01), Efrat
patent: 6410516 (2002-06-01), Baltimore et al.
patent: 6416959 (2002-07-01), Giuliano et al.
Traenckner, et al. The EMBO Journal, vol. 13, No. 22, pp. 5433-5441, 1994.
Ganchi et al. Molecular Biology of the Cell, 1992, vol. 3, pp. 1339-1352.
Baldwin, “The NF-κB and IκB proteins: New discoveries and insights”,Annu. Rev. Immunol.(1996) vol. 14: 649-683.
Bird. “Activation of nuclear transcription factor NF-κB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit”,J. Biol. Chem.,(1997) Vol. 272: 32606-32612.
Boyes, et al. Regulation of activity of the transcription factor GATA-1 by acetylation,Nature,(1998) vol. 396: 594-598.
Chakravarti, et al. “A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity”,Cell,(1999) vol. 96: 393-403.
Cress, et al. “Histone deacetylases, transcriptional control, and cancer”,J. Cell Physiol.,(2000) vol. 184: 1-16.
Deloukas, et al. “Genomic organization of the gene encoding the p65 subunit of NF-κB: Multiple variants of the p65 protein may be generated by alternative splicing”,Hum. Mol. Genet.,(1993) vol. 2 1895-1900.
Gerritsen, et al. “Creb-binding protein/p300 are transcriptional coactivators of p65”,Proc. Natl. Acad. Sci. USA,(1997) vol. 94: 2927-2932.
Ghosh, et al. NF-κB and rel proteins: Evolutionarily conserved mediators of immune responses,Annu. Rev. Immunol.(1998) vol. 16: 225-260.
Hamamori, et al. “Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral on oncoprotein E1A”,Cell,(1999) vol. 96: 405-413.
Hottiger. “Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300”,EMBO J.,(1998) vol. 17: 3124-3134.
Imhof, et al. “Transcription: Gene control by targeted histone acetylation”,Curr. Biol.,(1998) vol. 8, 422-424.
Jacobs, et al. “Structure of an I-kappa-B-alpha/NF-κB complex”,Cell,(1998) vol. 95(6) 749-758.
Karin. How NF-κB is activated: The role of the I-κB kinase (IKK) complex,Oncogene,(1999) vol. 18: 6867-6874.
Kouzarides. “Acetylation: A regulatory modification to rival phosphorylation?”,EMBO J.,(2000) vol. 19: 1176-1179.
Kraus, et al. “Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates”,Mol. Cell. Bio.,(1999) vol. 19: 8123-8135.
Kuo, et al. “Roles of histone acetyltransferases and deacetylases in gene regulation”,Bioessays,(1998) vol. 20: 615-626.
Lyle, et al. “An alternatively spliced transcript, p65 delta 2, of the gene encoding the p5 subunit of the transcription factor NF-κB”,Gene,(1994) vol. 138: 265-266.
Madge, et al. “A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NF-κB in human endothelial cells”,J. Biol. Chem.,(2000) vol. 275: 15458-15465.
Martínez-Balbás, et al. “Regulation of E2F1 activity by acetylation”,Embo. J.,(2000) vol. 19: 662-671.
May, et al. “Rel/NF-κB and I-κproteins: An overview”,Sem. Cancer Biol.(1997) vol. 8: 63-73.
May, et al. “Signal transduction through NF-κB”,Immunol. Today,(1998) vol. 19(2): 80-88.
Ng, et al. “Histone deacetylases: Silencers for hire”,TIBS,(2000) vol. 25: 121-126.
Perkins, et al. “Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator”,Science,(1997) vol. 275: 523-527.
Ruben, et al. “Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-κB”,Science,(1991) vol. 251: 1490-1493.
Rundlett, et al. “HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription”,Proc. Natl. Acad. Sci. USA,(1996) vol. 93: 14503-14508.
Sen, et al. “Multiple nuclear factors interact with the immunoglobulin enhancer sequences”,Cell,(1986) vol. 46: 705-716.
Sakurai. “I-κB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain”,J. Biol. Chem.,(1999) vol. 274: 30353-30356.
Sheppard, et al. “Transcriptional activation by NF-κB requires multiple coactivators”,Mol. Cell. Biol.,(1999) vol. 19: 6367-6378.
Sterner, et al. “Acetylation of histones and transcription-related factors”,Microbiol. Mol. Biol. Rev.,(2000) vol. 64: 435-459.
Sun, et al. “NF-κB controls expression of inhibitor I-κBβ: Evidence for an inducible autoregulatory pathway”,Science,(1993) vol. 259: 1912-1915.
Taunton, et al. “A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p”,Science,(1996) vol. 272: 408-411.
Wang. “Tumor necrosis factor β-induced phosphorylation of ReIA/p65 on Ser259is controlled by casein kinase II”,J. Biol. Chem.,(2000) vol. 275: 32592-32597.
Yoshida, et al. “Trichostatin and Ieptomycin: Inhibition of histone deactylation and signal-dependent nuclear export”,Ann N.Y. Acad. Sci.,(1999) vol. 886: 23-36.
Zhong, et al. “Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300”,Mol. Cell,(1998) vol. 1: 661-671.
Chen, Lin-feng et al., “Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation ”, Science 293 (5535) 1653-1657 (Aug. 2001).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for identifying modulators of NF-KB activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for identifying modulators of NF-KB activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for identifying modulators of NF-KB activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3593817

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.